The Next Evolution in Stem Cell Research
As a tenured professor at UT Health San Antonio, Dr. Xiao-Dong Chen was performing research with mesenchymal stem cells (MSCs) and, like many other cell researchers, became frustrated with unpredictable results when experimenting with expanded cells. All available cell expansion technologies changed the cells, causing them to lose potency during the process. Dr. Chen decided to use the microenvironment created by these cells as the basis for their expansion. This decision led him to develop the patented CELLvo™ Matrix, which allows cells to expand quickly and reliably without losing their stem-like properties.
Encouraged by the potential applications in research, diagnostic, and clinical settings, Dr. Chen co-founded StemBioSys® along with Dr. Steven Davis in 2010. Through a team of industry renowned professionals in business, research, and product development, StemBioSys has turned a single cell expansion platform into an extended line of high quality stem cells and cell expansion tools that are innovating the field of regenerative medicine. Key partnerships and research collaboration with MIT, Rutgers, UTSA, and BioBridge Global have enabled StemBioSys to continue discovering new and potential uses for their stem cell products that may lead to advances in clinical therapies for patients with Alzheimer's, Parkinson, Diabetes, heart conditions, and various cancers. Read the full story here...
CELLvo Technology platform
Request a Quote
To request a quote for our CELLvo™ Matrix for research use, please
CLICK HERE to complete the contact
information form or
call us at 210-877-9323.